Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiated Thyroid Gland Carcinoma”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Very early researchLooking for participantsNCT06639191
What this trial is testing

[177Lu]Lu-AKIR001 First-in-human Study

Who this might be right for
Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00181168
What this trial is testing

Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Johns Hopkins University 63
Large-scale testing (Phase 3)Not Yet RecruitingNCT07239674
What this trial is testing

Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

Who this might be right for
Intermediate-to-High Risk Differentiated Thyroid Cancer
West China Hospital 646
Testing effectiveness (Phase 2)Study completedNCT02973997
What this trial is testing

Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)

Who this might be right for
Columnar Cell Variant Thyroid Gland Papillary CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaMetastatic Thyroid Gland Follicular Carcinoma+23 more
Academic and Community Cancer Research United 57
Testing effectiveness (Phase 2)Study completedNCT01013597
What this trial is testing

Trial of LBH589 in Metastatic Thyroid Cancer

Who this might be right for
Thyroid Carcinoma
University of Wisconsin, Madison 13
Large-scale testing (Phase 3)Active Not RecruitingNCT03570021
What this trial is testing

ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Gustave Roussy, Cancer Campus, Grand Paris 352
Testing effectiveness (Phase 2)UnknownNCT04952493
What this trial is testing

Anlotinib or Penpulimab in Combination With RAI for DTC

Who this might be right for
Thyroid Cancer
Peking Union Medical College Hospital 42
Not applicableStudy completedNCT03787121
What this trial is testing

Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers

Who this might be right for
Thyroid Cancer
University Hospital, Toulouse 361
Testing effectiveness (Phase 2)Study completedNCT02702388
What this trial is testing

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Who this might be right for
Thyroid Cancer
Eisai Inc. 241
Very early researchLooking for participantsNCT06898437
What this trial is testing

Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Radioiodine Refractory Differentiated Thyroid Cancer
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04759911
What this trial is testing

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Who this might be right for
Malignant Thyroid Gland NeoplasmPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+4 more
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT05510934
What this trial is testing

Shared Care Thyroid Cancer Follow-up Utilizing Thyroid Cancer Assessment Reminder System (TCARS) Study - A Pilot Study.

Who this might be right for
Low Risk Differentiated Thyroid Cancer
Nova Scotia Health Authority 60
Testing effectiveness (Phase 2)Looking for participantsNCT06970353
What this trial is testing

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

Who this might be right for
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
Fudan University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007093
What this trial is testing

Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib

Who this might be right for
DTC - Differentiated Thyroid Cancer
Yansong Lin 20
Not applicableUnknownNCT04916262
What this trial is testing

Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer

Who this might be right for
Differentiated Thyroid CarcinomaTCM Syndrome Type
Qianfoshan Hospital 160
Not applicableUnknownNCT06154863
What this trial is testing

Recurrence in Patients With Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT01830504
What this trial is testing

Phase II Pilot Open Label

Who this might be right for
Thyroid Cancers
Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT02614495
What this trial is testing

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Hutchison Medipharma Limited 66
Not applicableApproved For MarketingNCT03533361
What this trial is testing

Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil

Who this might be right for
Thyroid Cancer
Eisai Inc.
Not applicableUnknownNCT04857086
What this trial is testing

The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China

Who this might be right for
Differentiated Thyroid Cancer
Huazhong University of Science and Technology 1,400
Next Page